Omega Fund Management, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001637359

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2023 · 12 positions · Total reported value $108.88M · Top-10 concentration 99.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 54.5% · 1 new · 4 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -24.0% · vs SPY -26.1% · Prev Value $185.69M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -24.7% · vs SPY -26.8% · Latest Value $125.16M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, Omega Fund Management, LLC disclosed 12 equity positions with a combined reported value of $108.88M. The filing implies a focused portfolio: its ten largest positions account for 99.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were REPL ($51.35M), NUVB ($20.20M), IKNA ($9.74M). By sector, the heaviest allocations are Health Care 75.7%, Other 24.3%.

Versus the prior quarter, Omega Fund Management, LLC opened 1 new positions, trimmed 4 and fully exited 1, a turnover rate of 54.5% of positions.

The largest new positions opened in Q3 2023 were REPL ($51.35M), NUVB ($20.20M), IKNA ($9.74M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • REPL REPLIMUNE GROUP INC · $51.35M
  • NUVB NUVATION BIO INC · $20.20M
  • IKNA IKENA ONCOLOGY INC · $9.74M
  • MORF MORPHIC HLDG INC · $7.10M
  • KRON KRONOS BIO INC · $4.96M
  • SPRB SPRUCE BIOSCIENCES INC · $4.88M
  • SANA SANA BIOTECHNOLOGY INC · $3.27M
  • IMUX IMMUNIC INC · $2.63M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Omega Fund Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Omega Fund Management, LLC, based in Boston, MA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 10 positions worth $185.69M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-74224 (status: Approved), registered 2012-03-30
  • Regulatory AUM (Form ADV): $1.71B as of 2026-03-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds
  • Website: omegafunds.com

Portfolio Structure

  • 10 positions · $185.69M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: BCAX (BICARA THERAPEUTICS INC) at 29.1%
  • Average position size: $18.57M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 new, 1 reduced, 1 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 75.7%
Other 24.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.00M $51.35M 47.17%
47.17%
New
2 15.07M $20.20M 18.55%
18.55%
New
3 2.25M $9.74M 8.95%
8.95%
New
4 309.85K $7.10M 6.52%
6.52%
New
5 3.82M $4.96M 4.56%
4.56%
New
6 2.16M $4.88M 4.49%
4.49%
New
7 843.75K $3.27M 3.00%
3.00%
New
8 1.79M $2.63M 2.41%
2.41%
New
9 711.48K $1.91M 1.76%
1.76%
New
10 153.70K $1.76M 1.62%
1.62%
New
11 251.27K $992.52K 0.91%
0.91%
New
12 195.79K $80.86K 0.07%
0.07%
New

FAQ

What did Omega Fund Management, LLC buy in 2023-Q3?

In its 2023-Q3 13F filing, Omega Fund Management, LLC reported 12 equity positions worth $108.88M in aggregate; its largest disclosed positions were REPL ($51.35M), NUVB ($20.20M), IKNA ($9.74M).

How large is Omega Fund Management, LLC's portfolio?

Omega Fund Management, LLC reported $108.88M of long equity holdings across 12 positions as of 2023-Q3. Top-10 holdings account for 99.0% of reported value.

What is Omega Fund Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/omega-fund-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →